Patent · US Active

Detecting fetal chromosomal abnormalities using tandem single nucleotide polymorphisms

US8663921B2 · kind B2 · utility

5Cited by
4References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 4, 2010
Grant dateMar 4, 2014
Priority date—
Expiry dateAug 4, 2030

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY10T436/143333
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The invention provides tandem single nucleotide polymorphisms and methods for their use, for example, in diagnosing Down Syndrome.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.